Zealand Pharma A/S
ZLDPF
$75.88
-$7.17-8.63%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 12,416.28% | 2,483.34% | -84.05% | -81.87% | -77.78% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 12,416.28% | 2,483.34% | -84.05% | -81.87% | -77.78% |
| Cost of Revenue | -93.56% | -117.76% | -78.44% | -33.72% | 44,632.26% |
| Gross Profit | 16,545.00% | 2,721.01% | -84.33% | -83.55% | -83.30% |
| SG&A Expenses | 82.25% | 71.74% | 74.49% | 86.58% | 53.44% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 379,012.99% | 13,734.61% | 1,312.19% | 63.60% | 100.62% |
| Total Operating Expenses | 79.48% | 78.72% | 46.58% | 46.74% | 32.92% |
| Operating Income | 768.34% | 1,158.17% | -116.25% | -125.89% | -102.14% |
| Income Before Tax | 807.42% | 1,166.89% | -58.30% | -52.90% | -39.77% |
| Income Tax Expenses | 13,101.67% | 12,385.33% | 4.17% | 9.81% | 21.96% |
| Earnings from Continuing Operations | 753.45% | 1,094.80% | -58.70% | -53.35% | -40.25% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 753.45% | 1,094.80% | -58.70% | -53.35% | -36.07% |
| EBIT | 768.34% | 1,158.17% | -116.25% | -125.89% | -102.14% |
| EBITDA | 783.41% | 1,190.28% | -121.61% | -139.14% | -110.02% |
| EPS Basic | 682.86% | 959.96% | -37.19% | -29.92% | -14.20% |
| Normalized Basic EPS | 711.87% | 1,005.93% | -76.96% | -72.08% | -39.66% |
| EPS Diluted | 673.63% | 943.72% | -36.75% | -29.50% | -13.88% |
| Normalized Diluted EPS | 702.27% | 989.05% | -76.29% | -71.41% | -39.23% |
| Average Basic Shares Outstanding | 11.45% | 17.28% | 16.16% | 17.40% | 18.29% |
| Average Diluted Shares Outstanding | 11.84% | 16.77% | 15.23% | 16.42% | 17.26% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |